Patents Examined by Suchira Pande
  • Patent number: 9005931
    Abstract: A programmable probe design of DNA micro array and detection methodology is provided. DNA probes, which are complemented with the target DNA, are designed and classified into groups according to optimum hybridization temperature. The probes are arrayed by the group and immobilized on the substrate surface of the DNA micro array. The control system, imaging system and temperature control system are programmed to cooperate with each other during the detection process. This design increases the detection capabilities of the parallel-analysis system.
    Type: Grant
    Filed: December 24, 2007
    Date of Patent: April 14, 2015
    Assignee: Honeywell International Inc.
    Inventors: Zhenhong Sun, Wendy Wang, Hang Liao
  • Patent number: 8999675
    Abstract: Nucleic acid assays for detecting nucleic acids of Dengue virus serotypes 1-4 derived from 5? NTR.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: April 7, 2015
    Assignee: Gen-Probe Incorporated
    Inventors: James M. Carrick, Jeffrey M. Linnen
  • Patent number: 8999633
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human pancreatic adenocarcinoma. A variety of chromosomal regions (MCRs) and markers in the MCRs, are provided that are correlated with cancer. In particular, chromosomal regions and markers in the MCR 50.06-62.89 Mb of human chromosome 19, are provided, wherein alterations in the copy number of the MCR and/or alterations in the amount, structure, and/or activity of one or more of the markers in the MCR is correlated with the presence of pancreatic adenocarcinoma.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: April 7, 2015
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Lynda Chin, Cameron W. Brennan, Ronald A. DePinho, Andrew J. Aguirre
  • Patent number: 8951730
    Abstract: Compositions and reaction mixtures are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and reaction mixtures provide for sensitive and specific detection of the target nucleic acids. The compositions and reaction mixtures include one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and reaction mixtures are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: February 10, 2015
    Assignee: Gen-Probe Incorporated
    Inventors: Amara Siva, Mark A. Reynolds
  • Patent number: 8940526
    Abstract: Devices, containers, and methods are provided for performing biological analysis in a closed environment. Illustrative biological analyzes include nucleic acid amplification and detection and immuno-PCR.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: January 27, 2015
    Assignee: BioFire Diagnostics, LLC
    Inventors: Kirk M. Ririe, Michael R. Newswander, Randy P. Rasmussen, Mark Aaron Poritz, Stewart Benjamin Smith, David E. Jones, Gary Clark Kessler
  • Patent number: 8921074
    Abstract: A method of determining a probability that a human test subject has colorectal cancer as opposed to not having colorectal cancer is disclosed.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: December 30, 2014
    Assignee: GeneNews, Inc.
    Inventors: Choong-Chin Liew, Samuel Chao
  • Patent number: 8921045
    Abstract: The invention provides a yeast-enhanced red fluorescent protein. In an embodiment of the invention, the yeast-enhanced red fluorescent protein is monomeric and is expressible in Candida albicans. The invention also provides a novel visible color marker for plasmid expression in yeast, particularly Saccharomyces cerevisiae and Candida albicans.
    Type: Grant
    Filed: February 26, 2009
    Date of Patent: December 30, 2014
    Assignee: The Research Foundation for The State University of New York
    Inventor: Neta Dean
  • Patent number: 8911989
    Abstract: The present invention provides a microfluidic biochip, which comprises: a fluid transportation unit having a fluid transportation reservoir and a fluid transportation air chamber; a first fluid storage reservoir; a second fluid storage reservoir; a first valve unit having a first valve and a first valve control air chamber; and a second valve unit having a second valve and a second valve control air chamber; wherein the first valve unit is located between the first fluid storage reservoir and the fluid transportation unit, the second valve unit is located between the second fluid storage reservoir and the fluid transportation unit, and the top portion of the fluid transportation reservoir and the valves are made of a flexible material. The structure of the present microfluidic biochip allows fluids to be transported and/or mixed therein.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: December 16, 2014
    Assignee: National Cheng Kung University
    Inventors: Gwo-Bin Lee, Sung-Yi Yang, Song-Bin Huang, Kang-Yi Lien, Chen-Hsun Weng
  • Patent number: 8911972
    Abstract: Systems and methods are provided for single-molecule sequencing of template nucleic acids in which the signal from a label attached to a polymerase enzyme is used to monitor conformational changes in the polymerase which occur while labeled nucleotides or nucleotide analogs are added to a growing nucleic acid chain which is complementary to the template nucleic acid. The signal indicative of the conformational state of the enzyme is used to determine with higher confidence when true nucleotide or nucleotide analog incorporation events occur, allowing for the improved quality of base calls and sequence determination.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: December 16, 2014
    Assignee: Pacific Biosciences of California, Inc.
    Inventors: Mark Chaisson, Sonya Clark, Christopher Silk, John Lyle, Lei Jia, Keith Bjornson
  • Patent number: 8815514
    Abstract: Disclosed are methods and compositions related to real-time PCR and other nucleic acid extension or amplification reactions.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: August 26, 2014
    Assignee: Co-Diagnostics, Inc.
    Inventors: Brent C. Satterfield, Rebecca Garcia
  • Patent number: 8765455
    Abstract: A non-contact system for sorting monodisperse water-in-oil emulsion droplets in a microfluidic device based on the droplet's contents and their interaction with an applied electromagnetic field or by identification and sorting.
    Type: Grant
    Filed: January 27, 2011
    Date of Patent: July 1, 2014
    Assignees: Lawrence Livermore National Security, LLC, The Regents of the University of California
    Inventors: Neil Reginald Beer, Abraham Lee, Andrew Hatch
  • Patent number: 8765652
    Abstract: The present invention relates to reagents for use in deactivating nucleic acids and methods of making and using the same.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: July 1, 2014
    Assignee: Gen-Probe Incorporated
    Inventors: Norman C. Nelson, Kenneth A. Browne, Lizhong Dai, James Russell, Mark E. Filipowsky, Margarita B. Kaminsky, Daniel L. Kacian
  • Patent number: 8753821
    Abstract: This invention is related to PNA probes, probe sets, mixtures, methods and kits pertaining to the determination of Mycoplasma and related Mollicutes.
    Type: Grant
    Filed: February 20, 2012
    Date of Patent: June 17, 2014
    Assignee: Applied Biosystems, LLC
    Inventors: Jens Hyldig-Nielsen, Susan Rigby, Michael Tanner, Ditte Lee, Byron Brehm-Stecher
  • Patent number: 8741605
    Abstract: The present invention provides gene sets the expression of which is important in the diagnosis and/or prognosis of breast cancer.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: June 3, 2014
    Assignee: Genomic Health, Inc.
    Inventors: Melody A. Cobleigh, Steve Shak, Joffre B. Baker, Maureen T. Cronin
  • Patent number: 8728765
    Abstract: The invention is directed to systems, methods, and apparatus for carrying out multi-stage amplification reactions, especially under fluidly closed conditions. In one aspect, methods of the invention are carried out in a fluidly closed reaction system that permits the isolation of a portion of a first (or prior) reaction mixture and its use as a sample or specimen in a second (or subsequent) reaction mixture, thereby substantially avoiding interfering effects that first reaction components may have in the second reaction if both reaction mixtures were simply combined together. In this aspect, systems, methods, and apparatus of the invention may be used with any amplification reaction that permits multiple stages of amplification based on the use of nested primers.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: May 20, 2014
    Assignee: Cepheid
    Inventors: Jesus Ching, Ronald Chang, Douglas Dority, Jian Ping Zhang, James Jian Quan Wang, Wendy Wong, Kendra Lara Paul, Reuel Van Atta
  • Patent number: 8697399
    Abstract: The present invention provides methods of determining the size of a particular nucleic acid segment of interest in a sample of nucleic acids through fragmentation of DNA, size fractionation, an optional second fragmentation, and identification using a marker sequence. In particular aspects, an expansion or reduction of tandem repeat sequences can be detected. In further aspects, carriers and individuals afflicted with fragile X syndrome or other diseases associated with tandem repeats can be distinguished from normal individuals.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: April 15, 2014
    Assignees: Quest Diagnostics Investments Incorporated, US Genomics, Inc.
    Inventors: Donghui Huang, Charles M. Strom, Steven J. Potts, Jenny Ellen Rooke
  • Patent number: 8669079
    Abstract: Methods for distinguishing between cotton species by analyzing a sample of mature cotton fibers from raw cotton materials or from textile goods are disclosed. DNA is extracted from the mature cotton fiber sample and subjected to PCR techniques which enable the identification of the species of cotton utilized in the textile or cotton material of interest.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: March 11, 2014
    Assignee: Cara Therapeutics, Inc.
    Inventors: Ming-Hwa Liang, Stephane Shu Kin So
  • Patent number: 8642294
    Abstract: Methods are described for determining the pattern of cytosine methylation in a DNA specimen, where the methods involve comparing the amount of DNA fragments generated by a methylation-sensitive restriction enzyme with the amount of DNA fragments generated by a methylation-insensitive isoschizomer of the methylation-sensitive restriction enzyme.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: February 4, 2014
    Assignees: Albert Einstein College of Medicine of Yeshiva University, The Research Foundation State University of New York
    Inventors: John M. Greally, Eli Hatchwell
  • Patent number: 8574864
    Abstract: The present innovation provides methods and kits that enable rapid and efficient dual end-tagging of RNA to prepare libraries for analysis by applications such as next-generation RNA sequencing, qPCR, microarray analysis, or cloning. The methods do not require time-consuming and inefficient gel-purification steps that are common to methods known in the art. In addition, the present invention provides methods and kits for rapid, high-throughput enzymatic preparation of 5?-activated, 3?-blocked DNA oligonucleotides from standard, single-stranded DNA oligonucleotides.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: November 5, 2013
    Assignee: Epicentre Technologies Corporation
    Inventors: Ramesh Vaidyanathan, Scott Kuersten, Ken Doyle
  • Patent number: RE45349
    Abstract: Harvesting the full richness of biodiversity is instantly recognized by Diversa Corporation as a powerful means to access both novel molecules having direct commercial utility as well as molecular templates that could be retooled to acquire commercial utility. A directed evolution process for rapid and facilitated production from a progenitor polynucleotide template, of a library of mutagenized progeny polynucleotides wherein each of the 20 naturally encoded amino acids is encoded at each original codon position. This method, termed site-saturation mutagenesis, or simply saturation mutagenesis, is preferably based on the use of the degenerate N,N,G/T sequence. Also, a method of non-stochastically producing a library of chimeric nucleic acid molecules having an overall assembly order that is chosen by design. Accordingly, a set of progenitor templates, such as genes (e.g. a family of esterase genes) or genes pathways (e.g.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: January 20, 2015
    Assignee: BP Corporation North America Inc.
    Inventor: Jay M. Short